TickerFacts.

Anaptysbio, Inc (ANAB): Share Repurchases

Annual figures by period end, from SEC filings.

$68.63M
Year ended 2025-12-31
$64.20M
Trailing 12 months to 2026-03-31
2015-12-31: $02016-12-31: $1.0K2017-12-31: $02018-12-31: $02021-12-31: $02022-12-31: $02023-12-31: $50.00M2024-12-31: $456.0K2025-12-31: $68.63M$68.63M
2015-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$68.63Mn/m2026-03-03, From 2025-01-01
2024-12-31$456.0K-99.1%2026-03-03, From 2024-01-01
2023-12-31$50.00Mn/a2026-03-03, From 2023-01-01
2022-12-31$0n/a2025-02-27, From 2022-01-01
2021-12-31$0n/a2024-03-11, From 2021-01-01
No annual figure between 2018-12-31 and 2021-12-31.
2018-12-31$0n/a2019-02-28, From 2018-01-01
2017-12-31$0-100.0%2019-02-28, From 2017-01-01
2016-12-31$1.0Kn/a2019-02-28, From 2016-01-01
2015-12-31$0n/a2018-03-05, From 2015-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Anaptysbio, Inc (ANAB)2025-12-31$68.63Mn/m
Keros Therapeutics, Inc. (KROS)2025-12-31$375.00Mn/a
Arvinas, Inc. (ARVN)2025-12-31$91.90Mn/a
Ligand Pharmaceuticals Inc (LGND)2025-12-31$15.00Mn/a
Lifevantage Corp (LFVN)2026-06-30$2.04M-35.1%
Cryoport, Inc. (CYRX)2025-12-31$10.01Mn/a
Innoviva, Inc. (INVA)2025-12-31$4.53M-69.3%
Nature's Sunshine Products Inc (NATR)2025-12-31$16.31M+84.1%
BridgeBio Pharma, Inc. (BBIO)2025-12-31$48.28Mn/a

Compare ANAB, KROS, ARVN, LGND side by side · Screen every company in Pharmaceutical Preparations ↗